北美天冬酰胺酶市场预测至 2028 年 - COVID-19 影响和区域分析(按类型(大肠杆菌、菊欧文氏菌、聚乙二醇化等)、应用(治疗、食品加工等)和最终用途行业(医疗保健和食品)制造业)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028


No. of Pages: 97    |    Report Code: BMIRE00027451    |    Category: Life Sciences

North America Asparaginase Market

北美天冬酰胺酶市场预计将从2022年的2.6771亿美元增长到2028年的6.6094亿美元;预计 2022 年至 2028 年复合年增长率为 16.3%。

天冬酰胺酶在制药和医疗领域的应用不断增加食品工业

制药和工业北美各地的食品工业发展迅速,并见证了各种发展,以保持食品和药品的高质量。如今,制造商越来越关注食品的营养成分。天冬酰胺酶是油炸和烘焙食品中减少糖分的主要氨基酸,这些食品是与羰基源缩合的。因此,该地区此类油炸和烘焙食品的消费量大幅增加。此外,天冬酰胺酶应用的不断增加正在推动食品和药品的需求,从而推动北美天冬酰胺酶市场的发展。

市场概览

北美天冬酰胺酶市场分为美国、加拿大和墨西哥。市场增长主要归因于该地区白血病和淋巴瘤患病率的上升。此外,美国占据天冬酰胺酶市场的最大份额。根据白血病和淋巴瘤协会称,2021 年,美国有 186,400 人被诊断患有淋巴瘤、白血病和骨髓瘤。淋巴瘤和白血病在儿童和青少年中很常见。大量人群的高患病率产生了对有效治疗的需求,从而增加了天冬酰胺酶的使用。结果,该国白血病和淋巴瘤的存活率有所提高。因此,对白血病和淋巴瘤治疗方案的需求不断增长,产生了对天冬酰胺酶的需求,从而推动了该国的市场增长。

北美到 2028 年天冬酰胺酶市场收入及预测(百万美元)

北美天冬酰胺酶市场细分

北美天冬酰胺酶市场根据类型、应用、最终用途行业、

根据类型,北美天冬酰胺酶市场分为大肠杆菌、菊欧文氏菌、聚乙二醇化酶等。 2022 年,大肠杆菌细分市场占据最大的市场份额。根据应用,北美天冬酰胺酶市场分为治疗、食品加工和其他领域。 2022年,治疗细分市场占据最大市场份额。治疗细分市场进一步细分为急性淋巴细胞白血病、淋巴母细胞淋巴瘤等。根据最终用途行业,北美天冬酰胺酶市场分为医疗保健和食品制造。 2022年,医疗保健领域占据了更大的市场份额。按国家划分,北美天冬酰胺酶市场分为美国、加拿大和墨西哥。此外,美国将在 2022 年占据市场主导地位。常州千红生物制药有限公司;创意酶;爵士制药公司;梅达克有限公司;施维雅制药有限责任公司;泰姬制药有限公司;和 United Biotech (P) Limited 是北美天冬酰胺酶市场的领先公司。



North America Asparaginase Strategic Insights

Strategic insights for North America Asparaginase involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-asparaginase-market-strategic-framework.webp
Get more information on this report

North America Asparaginase Report Scope

Report Attribute Details
Market size in 2022 US$ 267.71 Million
Market Size by 2028 US$ 660.94 Million
Global CAGR (2022 - 2028) 16.3%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By 类型
  • 大肠杆菌
  • 菊欧文氏菌
  • 聚乙二醇化
By 应用
  • 治疗
  • 食品加工
By 终端行业
  • 医疗保健
  • 食品制造
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
Market leaders and key company profiles
  • Biovendor, LLC
  • Changzhou Qianhong Biopharma Co Ltd
  • Creative Enzymes
  • Jazz Pharmaceuticals, Inc.
  • medac GMBH
  • Servier Pharmaceuticals LLC
  • Taj Pharmaceuticals Limited
  • United Biotech (P) Limited
  • Get more information on this report

    North America Asparaginase Regional Insights

    The regional scope of North America Asparaginase refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-asparaginase-market-geography.webp
    Get more information on this report

    The List of Companies - North America Asparaginase Market

    1. Biovendor, LLC
    2. Changzhou Qianhong Biopharma Co Ltd
    3. Creative Enzymes
    4. Jazz Pharmaceuticals, Inc.
    5. medac GMBH
    6. Servier Pharmaceuticals LLC
    7. Taj Pharmaceuticals Limited  
    8. United Biotech (P) Limited
    Frequently Asked Questions
    How big is the North America Asparaginase Market?

    The North America Asparaginase Market is valued at US$ 267.71 Million in 2022, it is projected to reach US$ 660.94 Million by 2028.

    What is the CAGR for North America Asparaginase Market by (2022 - 2028)?

    As per our report North America Asparaginase Market, the market size is valued at US$ 267.71 Million in 2022, projecting it to reach US$ 660.94 Million by 2028. This translates to a CAGR of approximately 16.3% during the forecast period.

    What segments are covered in this report?

    The North America Asparaginase Market report typically cover these key segments-

  • 类型 (大肠杆菌, 菊欧文氏菌, 聚乙二醇化)
  • 应用 (治疗, 食品加工)
  • 终端行业 (医疗保健, 食品制造)
  • What is the historic period, base year, and forecast period taken for North America Asparaginase Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Asparaginase Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in North America Asparaginase Market?

    The North America Asparaginase Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Biovendor, LLC
  • Changzhou Qianhong Biopharma Co Ltd
  • Creative Enzymes
  • Jazz Pharmaceuticals, Inc.
  • medac GMBH
  • Servier Pharmaceuticals LLC
  • Taj Pharmaceuticals Limited
  • United Biotech (P) Limited
  • Who should buy this report?

    The North America Asparaginase Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Asparaginase Market value chain can benefit from the information contained in a comprehensive market report.